{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:46:55Z","timestamp":1772664415875,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11107-x","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:36:25Z","timestamp":1748007385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"25","author":[{"given":"Abebe M.","family":"Aga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demise","family":"Mulugeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsbeha","family":"Gebreegziabxier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girum Taye","family":"Zeleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aderajew Mekonnen","family":"Girmay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gutema Bulti","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abaysew","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tigist","family":"Belete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tefera","family":"Taddele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiha","family":"Abubeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanos Tadesse","family":"Woldemariyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaye","family":"Gelanew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeweynshet","family":"Tesera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedasa","family":"Gidisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaleta Bulti","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemechu Tadesse","family":"Leta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senait Alemayehu","family":"Beshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedasa Wagari","family":"Likasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemal","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dereje","family":"Nigussie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"11107_CR1","doi-asserted-by":"crossref","unstructured":"Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, ... , Alroy-Preis S. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet,\u00a02021;397(10287):1819\u20131829.","DOI":"10.1016\/S0140-6736(21)00947-8"},{"key":"11107_CR2","doi-asserted-by":"crossref","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, ... , Zaks T. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.\u00a0N Engl J Med.\u00a02021;384(5):403\u2013416.","DOI":"10.1056\/NEJMoa2035389"},{"key":"11107_CR3","doi-asserted-by":"crossref","unstructured":"Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, ... , Izu A. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant.\u00a0N Engl J Med.\u00a02021;384(20):1885\u20131898.","DOI":"10.1056\/NEJMoa2102214"},{"issue":"15","key":"11107_CR4","doi-asserted-by":"publisher","first-page":"e34691","DOI":"10.1016\/j.heliyon.2024.e34691","volume":"10","author":"SJ Wimalawansa","year":"2024","unstructured":"Wimalawansa SJ. Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity. Heliyon. 2024;10(15):e34691.","journal-title":"Heliyon."},{"key":"11107_CR5","doi-asserted-by":"crossref","unstructured":"Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, Ranasinghe ON, ... , McLaughlin JM. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet.\u00a02021;398(10309):1407\u20131416.","DOI":"10.1016\/S0140-6736(21)02183-8"},{"key":"11107_CR6","doi-asserted-by":"crossref","unstructured":"Kennedy NA, Janjua M, Chanchlani N, Lin S, Bewshea C, Nice R, ... , Ahmad T. Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.\u00a0Gut.\u00a02023;72(2):295\u2013305.","DOI":"10.1136\/gutjnl-2022-327570"},{"key":"11107_CR7","doi-asserted-by":"crossref","unstructured":"Pulliam JR, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, ... , Moultrie H. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.\u00a0Science.\u00a02022;376(6593):eabn4947.","DOI":"10.1126\/science.abn4947"},{"issue":"9","key":"11107_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/vaccines10091545","volume":"10","author":"H Ke","year":"2022","unstructured":"Ke H, Chang MR, Marasco WA. Immune evasion of SARS-CoV-2 Omicron subvariants. Vaccines. 2022;10(9):1545.","journal-title":"Vaccines."},{"key":"11107_CR9","doi-asserted-by":"crossref","unstructured":"Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A, ... , Xie XS. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.\u00a0Nature.\u00a02023;614(7948):521\u2013529.","DOI":"10.1038\/s41586-022-05644-7"},{"issue":"12","key":"11107_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jama.2024.1036","volume":"331","author":"NW Andersson","year":"2024","unstructured":"Andersson NW, Thiesson EM, Hviid A. Adverse events after XBB. 1.5-containing COVID-19 mRNA vaccines. JAMA. 2024;331(12):1057\u20139.","journal-title":"JAMA."},{"key":"11107_CR11","doi-asserted-by":"crossref","unstructured":"Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher, E, ... , Lopez Bernal J. Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant.\u00a0N Engl J Med.\u00a02022;386(16):1532\u20131546.","DOI":"10.1056\/NEJMoa2119451"},{"key":"11107_CR12","doi-asserted-by":"crossref","unstructured":"Fryer HA, Geers D, Gommers L, Zaeck LM, Tan NH, Jones-Freeman B, ... , van Zelm, MC. Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2 -specific memory B cells to cross-recognize Omicron subvariants.\u00a0bioRxiv. 2024;2024\u201303.","DOI":"10.1101\/2024.03.20.585861"},{"key":"11107_CR13","doi-asserted-by":"crossref","unstructured":"Wang Q, Li Z, Ho J, Guo Y, Yeh AY, Mohri H, ... , Ho DD. Resistance of SARS-CoV-2 omicron subvariant BA. 4.6 to antibody neutralisation. Lancet Infect Dis.\u00a02022;22(12):1666\u20131668.","DOI":"10.1016\/S1473-3099(22)00694-6"},{"issue":"10","key":"11107_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41577-020-00451-5","volume":"20","author":"A Fontanet","year":"2020","unstructured":"Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583\u20134.","journal-title":"Nat Rev Immunol"},{"key":"11107_CR15","doi-asserted-by":"crossref","unstructured":"Hare D, Dembicka KM, Brennan C, Campbell C, Sutton-Fitzpatrick U, Stapleton PJ, ... , Dunne CP. Whole-genome sequencing to investigate transmission of SARS-CoV-2 in the acute healthcare setting: a systematic review.\u00a0J Hosp Infect. 2023.","DOI":"10.1016\/j.jhin.2023.08.002"},{"issue":"14","key":"11107_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.15585\/mmwr.mm7314a3","volume":"73","author":"RH Doshi","year":"2024","unstructured":"Doshi RH. COVID-19 Vaccination Coverage\u2014World Health Organization African Region, 2021\u20132023. MMWR Morb Mortal Wkly Rep. 2024;73(14):307\u201311.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"11107_CR17","doi-asserted-by":"crossref","unstructured":"Sisay A, Tshiabuila D, van Wyk S, Tesfaye A, Mboowa G, Oyola SO, ... , San JE. Molecular epidemiology and diversity of SARS-CoV-2 in Ethiopia, 2020\u20132022.\u00a0Genes.\u00a02023;14(3):705.","DOI":"10.3390\/genes14030705"},{"key":"11107_CR18","doi-asserted-by":"crossref","unstructured":"Yakob B, Girma T, Asefa F, Tora A, Keidar S, Tesfaye W, ... , Berman P. The Roles of Upstream Factors in Ethiopia\u2019s COVID-19 Pandemic Response. A World Scientific Reference on Pandemics: Volume 3: Jurisdictional Case Studies\u00a02025;195\u2013235.","DOI":"10.1142\/9789811296666_0010"},{"key":"11107_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.47102\/annals-acadmedsg.2022294","volume":"51","author":"TRT Chia","year":"2022","unstructured":"Chia TRT, Young BE, Chia PY. The Omicron-transformer: Rise of the subvariants in the age of vaccines. Ann Acad Med Singap. 2022;51:712\u201329.","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"11107_CR20","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1002\/mco2.239","volume":"4","author":"D Ao","year":"2023","unstructured":"Ao D, He X, Hong W, Wei X. The rapid rise of SARS\u2010CoV\u20102 Omicron subvariants with immune evasion properties: XBB. 1.5 and BQ. 1.1 subvariants. MedComm. 2023;4(2):e239.","journal-title":"MedComm."},{"key":"11107_CR21","doi-asserted-by":"crossref","unstructured":"Qu P, Faraone JN, Evans JP, Zheng YM, Carlin C, Anghelina M, ... , Liu SL. Enhanced evasion of neutralizing antibody response by Omicron XBB. 1.5, CH. 1.1, and CA. 3.1 variants.\u00a0Cell Rep.\u00a02023;42(5).","DOI":"10.1016\/j.celrep.2023.112443"},{"issue":"2","key":"11107_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s15010-023-02146-0","volume":"52","author":"A Esmaeilzadeh","year":"2024","unstructured":"Esmaeilzadeh A, Ebrahimi F, Jahani Maleki A, Siahmansouri A. EG. 5 (Eris) and BA. 2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19. Infection. 2024;52(2):337\u201343.","journal-title":"Infection."},{"key":"11107_CR23","doi-asserted-by":"crossref","unstructured":"Kumar A, Parashar R, Kumar S, Faiq MA, Kumari C, Kulandhasamy M, Narayan RK, Jha RK, Singh HN, Prasoon P, Pandey SN. Emerging SARS\u2010CoV\u20102 variants can potentially break set epidemiological barriers in COVID\u201019. J Med Virol. 2022;94(4):1300-14.","DOI":"10.1002\/jmv.27467"},{"key":"11107_CR24","doi-asserted-by":"crossref","unstructured":"Machado RRG, Candido \u00c9D, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, ... , Oliveira DBL. Immune evasion of SARS-CoV-2 Omicron subvariants XBB. 1.5, XBB. 1.16 and EG. 5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA. 4\/5 bivalent booster.\u00a0Vaccines.\u00a02024;12(2):144.","DOI":"10.3390\/vaccines12020144"},{"issue":"4","key":"11107_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/JS9.0000000000000246","volume":"109","author":"C Chakraborty","year":"2023","unstructured":"Chakraborty C, Bhattacharya M, Chopra H, Islam MA, Saikumar G, Dhama K. The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB. 1, and XBB. 1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties\u2013an alarming global threat of a surge in COVID-19 cases again? Int J Surg. 2023;109(4):1041\u20133.","journal-title":"Int J Surg."},{"key":"11107_CR26","doi-asserted-by":"crossref","unstructured":"Kandeel A, Eldeyahy I, Abu ElSood H, Fahim M, Afifi S, Abu Kamar S, ... , Abdelghaffar K. COVID-19 vaccination coverage in Egypt: a large-scale national survey\u2013to help achieving vaccination target, March-May, 2022.\u00a0BMC Public Health.\u00a02023;23(1):1\u201311.","DOI":"10.1186\/s12889-023-15283-w"},{"key":"11107_CR27","doi-asserted-by":"crossref","unstructured":"Stoddard M, Sarkar S, Nolan RP, White DE, White LF, Hochberg NS, Chakravarty A. Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2. MedRxiv. 2021:2021\u201301.","DOI":"10.1101\/2021.01.27.20240309"},{"issue":"1","key":"11107_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jmv.26243","volume":"93","author":"S Falahi","year":"2021","unstructured":"Falahi S, Kenarkoohi A. Sex and gender differences in the outcome of patients with COVID-19. J Med Virol. 2021;93(1):151.","journal-title":"J Med Virol"},{"issue":"4","key":"11107_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2450","volume":"33","author":"A Zovi","year":"2023","unstructured":"Zovi A, Ferrara F, Langella R, Cavallaro F, Vitiello A. Sex affects immune response capacity against COVID-19 infection. Rev Med Virol. 2023;33(4): e2450.","journal-title":"Rev Med Virol"},{"key":"11107_CR30","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2023068","volume":"45","author":"J Jeon","year":"2023","unstructured":"Jeon J, Park J, Choi MH, Choi H, Kim MH. Unequal burdens of COVID-19 infection: a nationwide cohort study of COVID-19-related health inequalities in Korea. Epidemiology and Health. 2023;45: e2023068.","journal-title":"Epidemiology and Health"},{"key":"11107_CR31","doi-asserted-by":"crossref","unstructured":"Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, ... , McCullough LD. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area.\u00a0PloS one.\u00a02021;16(1):e0245556.","DOI":"10.1371\/journal.pone.0245556"},{"issue":"3","key":"11107_CR32","first-page":"147","volume":"21","author":"O Puhach","year":"2023","unstructured":"Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2023;21(3):147\u201361.","journal-title":"Nat Rev Microbiol"},{"key":"11107_CR33","doi-asserted-by":"crossref","unstructured":"Puhach, O., Adea, K., Hulo, N., Sattonnet, P., Genecand, C., Iten, A., ... & Meyer, B. (2022). Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron.\u00a0MedRxiv, 2022\u201301.","DOI":"10.1101\/2022.01.10.22269010"},{"key":"11107_CR34","doi-asserted-by":"crossref","unstructured":"Yang Y, Guo L, Yuan J, Xu Z, Gu Y, Zhang J, ... , Liu Y. Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B. 1.1. 529): a prospective cohort study from Shenzhen, China. Lancet Microbe.\u00a02023;4(8):e632-e641.","DOI":"10.1016\/S2666-5247(23)00139-8"},{"key":"11107_CR35","doi-asserted-by":"crossref","unstructured":"Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, ... , Lemieux JE. Vaccine breakthrough infection with the SARS-CoV-2 Delta or Omicron (BA. 1) Variant leads to distinct profiles of neutralizing antibody responses.\u00a0medRxiv. 2022.","DOI":"10.1101\/2022.03.02.22271731"},{"key":"11107_CR36","doi-asserted-by":"crossref","unstructured":"Qu L, Xie C, Qiu M, Yi L, Liu Z, Zou L, ... , Lu J. Characterizing infections in two epidemic waves of SARS-CoV-2 Omicron variants: a Cohort Study in Guangzhou, China.\u00a0Viruses,\u00a02024;16(4):649.","DOI":"10.3390\/v16040649"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11107-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:36:32Z","timestamp":1748007392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11107-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11107"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11107-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethiopian Public Health Institute Institutional Review Board (EPHI_IRB) Approval No. 415_2022. All participants have provided informed consent, and data collectors have made it clear that participation is entirely voluntary and the study was conducted in accordance with Declaration of Helsinki. Participants retain the right to withdraw from the study at any time without affecting their access to healthcare services.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"738"}}